Login
Home / MNZO : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Manzo Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
115.95K
AVG Volume
4.05K
Trailing/Forward PE
-9.83/-
PEG ratio
-0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
020K40K60K04 Q304 Q405 Q326 Q1
Net Income (USD)
-1.5M-1M-500K0500K04 Q304 Q405 Q326 Q1
Operating Income (USD)
-1M-750K-500K-250K0250K04 Q304 Q405 Q326 Q1
EBITDA (USD)
-3M-2M-1M01M04 Q304 Q405 Q326 Q1
Cash Flows (USD)
-800K-600K-400K-200K004 Q4
EPS (USD)
-0.3-0.2-0.1-004 Q304 Q405 Q326 Q1
Expenses (USD)
0250K500K750K1MR&DSG&ACapex04 Q304 Q405 Q326 Q1
Cash & Debt (USD)
02M4M6M8MCashShort Term Debt04 Q405 Q3
Debt ratios
000004 Q405 Q3
Margins
0%10%20%30%40%26 Q1
Return on Capital
0%5%10%15%04 Q405 Q3
Shares Outstanding
02B4B6B04 Q304 Q405 Q326 Q1
Book Value Per Share (USD)
-8-6-4-2004 Q405 Q3
Total Assets (USD)
02M4M6M04 Q405 Q3
Price to Sales
02.557.510med 8.33Jul 26Jul 26Jul 26Aug 26Aug 26Sep 26
Manzo Pharmaceuticals, Inc.
MNZO
Stockpicker

Video analysis: MNZO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.